Dr. Christine Chung, MD
Claim this profileMoffitt Cancer Center
Studies Squamous Cell Carcinoma
Studies Cancer
13 reported clinical trials
27 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
p16 positive
p16 negative
2Cancer
p16 positive
Stage IV
p16 negative
Affiliated Hospitals
Clinical Trials Christine Chung, MD is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
ACR-368 + Gemcitabine
for Head and Neck Cancer
The purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Participants will receive the study drugs ACR-368 and a low dose of gemcitabine once every 2 weeks in 4-week cycles and will continue on treatment unless the disease deteriorates.
Recruiting1 award Phase 210 criteria
More about Christine Chung, MD
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Christine Chung, MD has experience with
- Pembrolizumab
- Intensity-Modulated Radiation Therapy
- Cisplatin
- Intervention
- Control
- Regular Eating Pattern
Breakdown of trials Christine Chung, MD has run
Squamous Cell Carcinoma
Cancer
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Chung, MD specialize in?
Christine Chung, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Christine Chung, MD currently recruiting for clinical trials?
Yes, Christine Chung, MD is currently recruiting for 6 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Christine Chung, MD has studied deeply?
Yes, Christine Chung, MD has studied treatments such as Pembrolizumab, Intensity-Modulated Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Christine Chung, MD?
Apply for one of the trials that Christine Chung, MD is conducting.
What is the office address of Christine Chung, MD?
The office of Christine Chung, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.